Harvard Bioscience
HBIO
#10461
Rank
C$38.47 M
Marketcap
C$8.53
Share price
-1.14%
Change (1 day)
1,325.57%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -C$13.64 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are C$85.53 Million. In 2025 the company made an earning of -C$80.79 Million a decrease over its 2024 earnings that were of -C$16.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$13.64 Million-83.13%
2025 -C$80.79 Million391.95%
2024 -C$16.43 Million356.38%
2023 -C$3.6 Million-72.15%
2022 -C$12.93 Million6456.43%
2021 -C$0.2 Million-98.08%
2020 -C$10.27 Million32.53%
2019 -C$7.75 Million-31.01%
2018 -C$11.23 Million243.9%
2017 -C$3.27 Million-24.66%
2016 -C$4.34 Million-14.69%
2015 -C$5.08 Million-181.68%
2014 C$6.21 M-9.97%
2013 C$6.9 M120%
2012 C$3.13 M-50.9%
2011 C$6.39 M-52.51%
2010 C$13.46 M-2.53%
2009 C$13.81 M28.26%
2008 C$10.76 M-20.05%
2007 C$13.47 M13.96%
2006 C$11.82 M17.59%
2005 C$10.05 M57.37%
2004 C$6.38 M-37.31%
2003 C$10.18 M208.03%
2002 C$3.3 M-168.71%
2001 -C$4.82 Million-66.89%
2000 -C$14.54 Million